Cancer News and Research

Latest Cancer News and Research

Study shows CEL-2000 vaccine blocks RA progression in mice

CEL-SCI Corporation and their scientific collaborators announced today that the Company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model.

23 Feb 2010

Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge

Star Scientific, Inc. announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDL™ as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.

23 Feb 2010

MRI: An efficient diagnostic tool for testicular cancer

Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology.

23 Feb 2010

CINJ researchers test malaria drug for colorectal cancer treatment

While new cases of colorectal cancer continue to decline in the United States, it remains the third leading cause of cancer death in the nation, according to the American Cancer Society. That is why researchers at The Cancer Institute of New Jersey are looking to add a drug known for fighting malaria to traditional chemotherapy for colorectal cancer to see if treatment can be made more effective for patients.

23 Feb 2010

Medical test for aging adults could be helpful in determining infants’ intestinal conditions

A medical test initially researched for aging adults also could be helpful for premature babies, according to scientists with Texas AgriLife Research.

23 Feb 2010

Cancer Institute awards MCRA designation to Cooper University Hospital

Enhancing its collective strength in the area of oncology research in the state, The Cancer Institute of New Jersey has announced that Cooper University Hospital will be the fourth affiliate hospital within its Network to receive the prestigious Major Clinical Research Affiliate designation.

23 Feb 2010

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.

23 Feb 2010

Nation-wide study to assess risk of suicide among men

The introduction of prostate-specific antigen (PSA) testing as a screening tool for early detection of prostate cancer (PCa) in the beginning of the 1990s drastically increased the detection of PCa. The risk of suicide is increased among cancer patients including men with PCa.

23 Feb 2010

Researchers measure diffusion coefficient of a protein in a primary cilium

A team of researchers led by Peter Calvert (SUNY Upstate Medical University) has, for the first time, measured the diffusion coefficient of a protein in a primary cilium and in other major compartments of a highly polarized cell. The study appears in the March issue of the Journal of General Physiology.

22 Feb 2010

Ritter Pharmaceuticals to discuss lactose intolerance and associated health risks at NIH Conference

Ritter Pharmaceuticals, a company dedicated to helping individuals live a healthier and happier life style through improved digestion, announced today that it will join the leading lactose intolerance experts around the country at the NIH Consensus Development Conference for Lactose Intolerance and Health in Bethesda, Maryland from February 22-24.

22 Feb 2010

BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data

BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.

22 Feb 2010

UIC researchers receive federal grant to study effects of TV media on children’s health outcomes

Researchers at the University of Illinois at Chicago Institute for Health Research and Policy have received a $2.2 million federal grant to determine whether or not TV food advertising affects children's diet, physical activity and weight.

22 Feb 2010

RNCRR uses Parascript' AccuDetect CAD software to detect breast cancer

Parascript, LLC, the image analysis and pattern recognition solution provider, today announced the use of its AccuDetect computer aided detection (CAD) software by the Russian Center for Roentgeno - Radiology Research in Moscow. RNCRR is Russia's largest, most recognized breast cancer oncology center.

22 Feb 2010

Cord Blood America announces aim to be world's largest stem cell storage facility

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, for families nationwide and internationally, said today in an interview of Matthew Schissler, co-founder and CEO, by analyst Francis Gaskins, that its goal is to be the world's largest stem cell storage facility.

22 Feb 2010

Researchers use new technology to reveal different genetic patterns of neuroblastoma

Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden and Karolinska Institutet have used novel technology to reveal the different genetic patterns of neuroblastoma, an aggressive form of childhood cancer. This discovery may lead to significant advances in the treatment of this malignant disease, which mainly affects small children.

22 Feb 2010

Greater New York City Affiliate of Susan G. Komen for the Cure commences one-year celebration of its 20th anniversary

The Greater New York City Affiliate of Susan G. Komen for the Cure® is kicking off a one-year celebration of its 20th anniversary with the publication of its first-ever eight-page full-color newsletter looking back on the past 20 years, recapping 2009 and gazing into the organization’s future.

22 Feb 2010

BHL litigation against Health Diagnostic Laboratory: Celera addresses business impact

Celera Corporation today provided information on litigation filed by Berkeley HeartLab, Inc. (“BHL”), Celera’s wholly-owned subsidiary, against Health Diagnostic Laboratory, Inc. and several former employees of BHL, including five sales representatives who left the Company on January 1, 2010, and two former laboratory employees.

22 Feb 2010

Smokers, tobacco users and high alcohol consumers: Get mouths, gums and tongues checked for cancer

The National Basketball Association's (NBA) Denver Nuggets Coach George Karl announced today that he has been diagnosed with treatable neck and throat cancer. According to published media reports, Karl's physician says the coach has cancer of his right tonsil that has spread to a lymph node in his neck. The 58-year-old Karl, who is also a prostate cancer survivor, coached in the NBA's All-Star game this past weekend.

22 Feb 2010

Rewarding health care organizations for large-scale improvement will help accelerate improvement in care and quality

Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.

22 Feb 2010

Researchers identify common gene variant associated with atrial fibrillation

An international research team has identified a common gene variant associated with a form of the irregular heartbeat called atrial fibrillation. In their report in the journal Nature Genetics, being published online, the investigators describe finding that variations affecting a protein that may help control the heart's electrical activity appear to increase the risk of what is called lone atrial fibrillation (AF), a type seen in younger individuals with no other form of heart disease.

22 Feb 2010

Cancer News and Research

Latest Cancer News and Research

Study shows CEL-2000 vaccine blocks RA progression in mice

Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge

MRI: An efficient diagnostic tool for testicular cancer

CINJ researchers test malaria drug for colorectal cancer treatment

Medical test for aging adults could be helpful in determining infants’ intestinal conditions

Cancer Institute awards MCRA designation to Cooper University Hospital

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Nation-wide study to assess risk of suicide among men

Researchers measure diffusion coefficient of a protein in a primary cilium

Ritter Pharmaceuticals to discuss lactose intolerance and associated health risks at NIH Conference

BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data

UIC researchers receive federal grant to study effects of TV media on children’s health outcomes

RNCRR uses Parascript' AccuDetect CAD software to detect breast cancer

Cord Blood America announces aim to be world's largest stem cell storage facility

Researchers use new technology to reveal different genetic patterns of neuroblastoma

Greater New York City Affiliate of Susan G. Komen for the Cure commences one-year celebration of its 20th anniversary

BHL litigation against Health Diagnostic Laboratory: Celera addresses business impact

Smokers, tobacco users and high alcohol consumers: Get mouths, gums and tongues checked for cancer

Rewarding health care organizations for large-scale improvement will help accelerate improvement in care and quality

Researchers identify common gene variant associated with atrial fibrillation

Industry Focus eBook: Oncology eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook: Oncology eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in